Explore more publications!
Guyana Health Review
Got News to Share?

Guyana Health Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guyana Health Review.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 13, 2026

BiomX Accelerates Defense Technology Buildout with DFSL Acquisition
an hour ago

BiomX Accelerates Defense Technology Buildout with DFSL Acquisition

Indeterminate GlobeNewswire
PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026
an hour ago

PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026

Indeterminate GlobeNewswire
SafeSpace Global Corporation Announces Operational Expansion to Support Commercial Deployment of its AI-safety platform and Growing Revenue Activities
an hour ago

SafeSpace Global Corporation Announces Operational Expansion to Support Commercial Deployment of its AI-safety platform and Growing Revenue Activities

Indeterminate GlobeNewswire
Switchback Medical Signs Lease for 18,000 Square Foot Facility in Costa Rica’s Coyol Free Trade Zone
an hour ago

Switchback Medical Signs Lease for 18,000 Square Foot Facility in Costa Rica’s Coyol Free Trade Zone

Indeterminate GlobeNewswire
Switchback Medical firma contrato de arrendamiento para una instalación de 18,000 pies cuadrados en la Zona Franca Coyol de Costa Rica
an hour ago

Switchback Medical firma contrato de arrendamiento para una instalación de 18,000 pies cuadrados en la Zona Franca Coyol de Costa Rica

Indeterminate GlobeNewswire
Neomorph Announces Closing of $100 Million Series B Financing
an hour ago

Neomorph Announces Closing of $100 Million Series B Financing

Indeterminate GlobeNewswire
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
an hour ago

Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026

Indeterminate GlobeNewswire
Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month
an hour ago

Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month

Indeterminate GlobeNewswire
Xealth to Facilitate Critical Discussion Among Health System Executives on How to Maximize Digital Health Value at Becker’s Annual Meeting
2 hours ago

Xealth to Facilitate Critical Discussion Among Health System Executives on How to Maximize Digital Health Value at Becker’s Annual Meeting

Indeterminate GlobeNewswire
Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners
2 hours ago

Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners

Indeterminate GlobeNewswire
ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
2 hours ago

ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

Indeterminate GlobeNewswire
Oragenics Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury
2 hours ago

Oragenics Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury

Indeterminate GlobeNewswire
Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting
2 hours ago

Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting

Indeterminate GlobeNewswire
Heartflow Files Patent Infringement Lawsuit Against Cleerly
2 hours ago

Heartflow Files Patent Infringement Lawsuit Against Cleerly

Indeterminate GlobeNewswire
Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies
2 hours ago

Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies

Indeterminate GlobeNewswire
Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement
2 hours ago

Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement

Indeterminate GlobeNewswire
Nanox Signs Distribution Agreement with Digital X-Ray Imaging to Expand Nanox.ARC Adoption in Arkansas
2 hours ago

Nanox Signs Distribution Agreement with Digital X-Ray Imaging to Expand Nanox.ARC Adoption in Arkansas

Indeterminate GlobeNewswire
Veld Pharmaceuticals GmbH Announces Collaboration with Chiesi Farmaceutici S.p.A to Expand Access to Rare Disease Therapies Across Africa
2 hours ago

Veld Pharmaceuticals GmbH Announces Collaboration with Chiesi Farmaceutici S.p.A to Expand Access to Rare Disease Therapies Across Africa

Indeterminate GlobeNewswire
ImPact Biotech Presents Preliminary Data from Phase 1 Study of Padeliporfin VTP in LA-PDAC at SIR 2026 and Provides Strategic Business Update
2 hours ago

ImPact Biotech Presents Preliminary Data from Phase 1 Study of Padeliporfin VTP in LA-PDAC at SIR 2026 and Provides Strategic Business Update

Indeterminate GlobeNewswire
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary
2 hours ago

Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions